MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
18.77
+0.60 (3.30%)
At close: Feb 20, 2026, 4:00 PM EST
18.70
-0.07 (-0.37%)
After-hours: Feb 20, 2026, 7:59 PM EST
MLTX Market Cap
MLTX has a market cap or net worth of $1.34 billion as of February 20, 2026. Its market cap has decreased by -54.44% in one year.
Market Cap
1.34B
Enterprise Value
1.03B
1-Year Change
-54.44%
Ranking
Category
Stock Price
$18.77
Market Cap Chart
Since February 14, 2022, MLTX's market cap has increased from $3.60M to $1.34B, an increase of 37,133.26%. That is a compound annual growth rate of 336.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 1.34B | 42.41% |
| Dec 31, 2025 | 940.70M | -72.45% |
| Dec 31, 2024 | 3.41B | -5.66% |
| Dec 29, 2023 | 3.62B | 784.47% |
| Dec 30, 2022 | 409.26M | 11,274.54% |
| Feb 14, 2022 | 3.60M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zenas BioPharma | 1.40B |
| Savara | 1.39B |
| Corvus Pharmaceuticals | 1.38B |
| Trevi Therapeutics | 1.37B |
| Immatics | 1.32B |
| Taysha Gene Therapies | 1.29B |
| Nanobiotix | 1.27B |
| EyePoint | 1.26B |